(Q33490882)

27 July 2017

title

Procoagulant activity of the MC28 fibrosarcoma cell line in vitro and in vivo (English)

1 reference

27 July 2017

Amirkhosravi M

1

1 reference

27 July 2017

Francis JL

series ordinal

2

1 reference

27 July 2017

language of work or name

English

0 references

publication date

1 December 1993

1 reference

British Journal of Haematology

27 July 2017

published in

1 reference

27 July 2017

volume

85

1 reference

27 July 2017

issue

4

1 reference

27 July 2017

page(s)

736-744

1 reference

Immunohistochemical identification of tissue factor in solid tumors

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1993.TB03217.X

Fibrin as a component of the tumor stroma: origins and biological significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1993.TB03217.X

The effect of Warfarin and factor VII on tissue procoagulant activity and pulmonary seeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1993.TB03217.X

Cancer procoagulant A: A factor X activating procoagulant from malignant tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1993.TB03217.X

The role of blood platelets in experimental metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1993.TB03217.X

Factor X-activating activity from Lewis lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1993.TB03217.X

Acquired factor X deficiency and disseminated intravascular coagulation in a case of metastasizing carcinoma of the stomach and its course under chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1993.TB03217.X

METHOD USING ORTHO-TOLIDINE FOR THE QUANTITATIVE DETERMINATION OF HAEMOGLOBIN IN SERUM AND URINE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1993.TB03217.X

Coincidence of acquired factor-X deficiency and disseminated intravascular coagulation in patients with acute nonlymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1993.TB03217.X

Tissue factor as a tumor procoagulant

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1993.TB03217.X

Hemostatic alterations in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1993.TB03217.X

Procoagulant activity of mononuclear phagocytes from different anatomical sites in patients with gynecological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1993.TB03217.X

Correlation of the in vivo anticoagulant, antithrombotic, and antimetastatic efficacy of warfarin in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1993.TB03217.X

Hemostatic Abnormalities in Malignancy, a Prospective Study of One Hundred Eight Patients: Part I. Coagulation Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1993.TB03217.X

10.1111/J.1365-2141.1993.TB03217.X

21 January 2018

Identifiers

DOI

1 reference

27 July 2017

1 reference